These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 34257606)

  • 1. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
    Lin H; Zeng W; Lei Y; Chen D; Nie Z
    Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway.
    Zhao Z; Liu H; Hou J; Li T; Du X; Zhao X; Xu W; Xu W; Chang J
    Oncol Res; 2017 May; 25(5):773-779. PubMed ID: 27983909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
    Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLAUR facilitates the progression of clear cell renal cell carcinoma by activating the PI3K/AKT/mTOR signaling pathway.
    Qin T; Huang M; Wei W; Zhou W; Tang Q; Huang Q; Tang N; Gai S
    PeerJ; 2024; 12():e17555. PubMed ID: 38948215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-203 inhibits epithelial-mesenchymal transition, migration, and invasion of renal cell carcinoma cells via the inactivation of the PI3K/AKT signaling pathway by inhibiting CAV1.
    Han N; Li H; Wang H
    Cell Adh Migr; 2020 Dec; 14(1):227-241. PubMed ID: 32990143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
    Zhu Q; Zhong AL; Hu H; Zhao JJ; Weng DS; Tang Y; Pan QZ; Zhou ZQ; Song MJ; Yang JY; He JY; Liu Y; Li M; Hu WM; Yang CP; Xiang T; Chen MY; Ma G; Guo L; Xia JC
    J Hematol Oncol; 2020 Jan; 13(1):2. PubMed ID: 31900208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
    Li DY; Lin FF; Li GP; Zeng FC
    Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z; Ma Z; Xu X
    Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of ETS2 inhibits the invasion and metastasis of renal cell carcinoma cells by inducing EMT via the PI3K/Akt signaling pathway.
    Zhang GW; Tian X; Li Y; Wang ZQ; Li XD; Zhu CY
    Biomed Pharmacother; 2018 Aug; 104():119-126. PubMed ID: 29772431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca
    Dou C; Zhou Z; Xu Q; Liu Z; Zeng Y; Wang Y; Li Q; Wang L; Yang W; Liu Q; Tu K
    Oncogene; 2019 Feb; 38(8):1239-1255. PubMed ID: 30250300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway.
    Lin Y; Yang Z; Xu A; Dong P; Huang Y; Liu H; Li F; Wang H; Xu Q; Wang Y; Sun D; Zou Y; Zou X; Wang Y; Zhang D; Liu H; Wu X; Zhang M; Fu Y; Cai Z; Liu C; Wu S
    Sci Rep; 2015 Mar; 5():8997. PubMed ID: 25757764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
    Yuan H; Meng X; Guo W; Cai P; Li W; Li Q; Wang W; Sun Y; Xu Q; Gu Y
    Neoplasia; 2015 May; 17(5):410-20. PubMed ID: 26025664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
    Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W
    Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.